1. 1021. HIV-1 RNA Blips and Low-Level Replication During Phase III/IIIb Cabotegravir + Rilpivirine Long-Acting Studies Are Similar to Oral 3-Drug Therapy and Not Associated with Week 48 Virologic Outcome. (31st December 2020) Authors: Talarico, Christine L; Wu, Sterling; Upadhyay, Ojesh R; Clair, Marty St; Van Eygen, Veerle; Hudson, Krischan J; Griffith, Sandy; Harrington, Conn M; van Lunzen, Jan; Margolis, David; Spreen, William Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S540 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 96-Week Resistance Analyses of Rilpivirine in Treatment-Naive, HIV-1-Infected Adults from the Echo and Thrive Phase Iii Trials. Issue 8 (November 2013) Authors: Rimsky, Laurence; Van Eygen, Veerle; Hoogstoel, Annemie; Stevens, Marita; Boven, Katia; Picchio, Gaston; Vingerhoets, Johan Journal: Antiviral therapy Issue: Volume 18:Issue 8(2013) Page Start: 967 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Compassionate use of long‐acting cabotegravir plus rilpivirine for people living with HIV‐1 in need of parenteral antiretroviral therapy. Issue 2 (9th August 2022) Authors: D'Amico, Ronald; Cenoz Gomis, Santiago; Moodley, Riya; Van Solingen‐Ristea, Rodica; Baugh, Bryan; Van Landuyt, Erika; Van Eygen, Veerle; Min, Sherene; Cutrell, Amy; Foster, Caroline; Chilton, Daniella; Allard, Sabine D.; Ruiter, Annemiek Journal: HIV medicine Issue: Volume 24:Issue 2(2023) Page Start: 202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Deep sequencing analysis of HIV‐1 reverse transcriptase at baseline and time of failure in patients receiving rilpivirine in the phase III studies ECHO and THRIVE. Issue 5 (5th October 2015) Authors: Van Eygen, Veerle; Thys, Kim; Van Hove, Carl; Rimsky, Laurence T.; De Meyer, Sandra; Aerssens, Jeroen; Picchio, Gaston; Vingerhoets, Johan Journal: Journal of medical virology Issue: Volume 88:Issue 5(2016) Page Start: 798 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis. (15th July 2021) Authors: Cutrell, Amy G.; Schapiro, Jonathan M.; Perno, Carlo F.; Kuritzkes, Daniel R.; Quercia, Romina; Patel, Parul; Polli, Joseph W.; Dorey, David; Wang, Yongwei; Wu, Sterling; Van Eygen, Veerle; Crauwels, Herta; Ford, Susan L.; Baker, Mark; Talarico, Christine L.; Clair, Marty St; Jeffrey, Jerry; Whit... Journal: AIDS Issue: Volume 35:Number 9(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study. Issue 4 (April 2021) Authors: Orkin, Chloe; Oka, Shinichi; Philibert, Patrick; Brinson, Cynthia; Bassa, Ayesha; Gusev, Denis; Degen, Olaf; García, Juan González; Morell, Enrique Bernal; Tan, Darrell H S; D'Amico, Ronald; Dorey, David; Griffith, Sandy; Thiagarajah, Shanker; St Clair, Marty; Van Solingen-Ristea, Rodica; Crauwel... Journal: Lancet Issue: Volume 8:Issue 4(2021) Page Start: e185 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials. (1st December 2020) Authors: Rizzardini, Giuliano; Overton, Edgar T.; Orkin, Chloe; Swindells, Susan; Arasteh, Keikawus; Górgolas Hernández-Mora, Miguel; Pokrovsky, Vadim; Girard, Pierre-Marie; Oka, Shinichi; Andrade-Villanueva, Jaime F.; Richmond, Gary J.; Baumgarten, Axel; Masiá, Mar; Latiff, Gulam; Griffith, Sandy; Harrin... Journal: Journal of acquired immune deficiency syndromes Issue: Volume 85:Number 4(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Long-term safety and efficacy of rilpivirine in combination with nucleoside/nucleotide reverse transcriptase inhibitors in HIV-1 infected patients: 336-week rollover study of phase 2b and 3 clinical studies. Issue 6 (November 2021) Authors: Molina, Jean Michel; Ene, Luminita; Cahn, Pedro; Fätkenheuer, Gerd; Van Wijngaerden, Eric; Lombaard, Johan; Zakharova, Natalia; Van Eygen, Veerle; Vanveggel, Simon; Van Solingen-Ristea, Rodica Journal: Antiviral therapy Issue: Volume 26:Issue 6/8(2021) Page Start: 95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Minor variant detection in amplicons using 454 massive parallel pyrosequencing: experiences and considerations for successful applications. (September 2011) Authors: Vandenbroucke, Ina; Van Marck, Herwig; Verhasselt, Peter; Thys, Kim; Mostmans, Wendy; Dumont, Stéphanie; Van Eygen, Veerle; Coen, Katrien; Tuefferd, Marianne; Aerssens, Jeroen Journal: Biotechniques Issue: Volume 51:Number 3(2011) Page Start: 67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Pre-existence and Persistence of Resistant Minority Hepatitis C Virus Variants in Genotype 1-Infected Patients Treated With Simeprevir/Peginterferon/Ribavirin. (14th March 2016) Authors: Fevery, Bart; Thys, Kim; Van Eygen, Veerle; Verbinnen, Thierry; Van Rossem, Elizabeth; Buelens, Annemie; Aerssens, Jeroen; Witek, James; Picchio, Gaston; De Meyer, Sandra; Lenz, Oliver Journal: Open forum infectious diseases Issue: Volume 3:Number 2(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗